14 mar 2017
Dermatite atopica. Un problema anche per l'adulto e con incidenza in aumento
Questa patologia colpisce oggi il 2-5% della popolazione. Nelle sue forme più gravi il costante prurito e le manifestazioni dei sintomi sulla pelle portano a ripercussioni psicologiche forti per i pazienti. Sanofi e Regeneron Pharmaceuticals, Inc hanno presentato un farmaco sperimentale che sembra garantire un risultato migliore rispetto alle terapie più classiche a base di cortisone.
14 mar 2017
Spray Replaces Lost Skin Bacteria, Improves Keratosis Pilaris
A treatment that replaces natural-biome bacteria with ammonia-oxidising bacteria appears to improve the cosmetic appearance and texture of keratosis pilaris, according to results of a small phase 2 study reported at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)
14 mar 2017
Patients With Immunosuppressive Diseases/Treatments Experience Greater Complications After Mohs Surgery
The risk of a patient having a complication following Mohs Micrographic Surgery increases if that patient has a history of immunosuppressive diseases or treatments, according to results of a 4-year retrospective, chart review presented at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)
14 mar 2017
Topical Oxymetazoline 1.0% Shows Long-Term Efficacy for Persistent Facial Erythema Associated With Rosacea
Patients were able to tolerate treatment of their rosacea with topical 1% oxymetazoline hydrochloride gel for 1 year with acceptable reduction of redness and few adverse events, according to a study presented here at the 75th Annual Meeting of the American Academy of Dermatology (AAD)
13 mar 2017
Ixekizumab Superior to Ustekinumab for Treating Psoriasis
Patients with psoriasis treated with the targeted agent ixekizumab appear to have better outcomes at 24 weeks than those treated with ustekinumab, according to the 24-week data of the ongoing IXORA-S trial presented at the 2017 Annual Meeting of the American Academy of Dermatology (AAD)
13 mar 2017
Patients Aged Older Than 85 Years Who Have Mohs Surgery Average 6 More Years of Life
Patients aged older than 85 years can safely undergo Mohs micrographic surgery to remove non-melanoma skin cancer and still have years of good quality of life, researchers reported here at the 75th Annual Meeting of the American Academy of Dermatology (AAD)
13 mar 2017
Psoriasi, la terapia non è sufficiente per un malato su cinque
Un quinto dei pazienti seguiti con la cosiddetta «terapia sistemica» continua ad avere problemi significativi. Non bastano solo i farmaci, serve anche la pratica di stili di vita corretti: fumo e sovrappeso peggiorano le lesioni
13 mar 2017
Psoriasi, con la depressione sale il rischio di sviluppare artrite psoriasica?
Psoriasi e depressione, un'accoppiata nota da tempo ma da tenere sotto controllo.
13 mar 2017
Psoriasi. Niente vita di coppia per il 75% dei pazienti
Il 90% dei soggetti con psoriasi genitale dichiara effetti negativi sull’umore, il 75% dice addio alla propria vita sessuale e il 55% riporta una riduzione del desiderio sessuale a causa della malattia. Questi i dati presentati all’annuale appuntamento all’American Academy of Dermatology di Orlando
13 mar 2017
Psoriasi. Presentati al meeting annuale dell'American Academy of Dermatology i risultati di ixekizumab
Arrivano dall'Annual Meeting dell'American Academy of Dermatology in corso a Orlando i dati sull'efficacia a lungo termine di ixekizumab di Eli Lilly per la cura della psoriasi in forma da moderata a grave.
10 mar 2017
Delibera del CD relativa ai patrocini SIDeMaST
Il Consiglio direttivo in data 26 gennaio 2017 ha deliberato che il patrocinio SIDeMaST venga concesso a tutte le iniziative in cui la Direzione Scientifica sia di un socio SIDeMaST e per le quali il CD abbia approvato il programma scientifico; delibera inoltre che l'utilizzo del marchio è riservato alle sole attività erogate da SIDeMaST
10 mar 2017
World directory of Psoriasis medical resources for patients
Since 2013, the Psoriasis International Network (PIN) is listing services provided to psoriasis patients in dermatology centres worldwide and building an interactive directory
07 mar 2017
La psoriasi può causare perdita dei capelli?
Il cuoio capelluto è una delle sedi più frequentemente colpite e spesso rappresenta la sede di esordio della malattia che, inizialmente, può essere identificata dal paziente come «forfora» particolarmente persistente.
07 mar 2017
Absent Tumour-Suppressors Allow Melanoma to Thwart Immunotherapy
It's what's missing in the tumour genome -- not what's mutated -- that thwarts treatment of metastatic melanoma with immune checkpoint blockade drugs, according to a study published in the journal Science Translational Medicine
07 mar 2017
Risk of Subsequent Malignancies Reduced Among Childhood Cancer Survivors
Although the risk of subsequent malignancies for survivors of childhood cancer diagnosed in the 1990s remains increased, the risk is lower compared with those diagnosed in the 1970s -- a decrease that is associated with a reduction in therapeutic radiation dose, according to a study published in the February 28 issue of JAMA.
27 feb 2017
Gut Bacteria Associated With Cancer Immunotherapy Response in Melanoma
Patients with melanoma patients' response to a major form of immunotherapy is associated with the diversity and makeup of trillions of potential allies and enemies found in the digestive tract, according to a study presented at the 1st American Society of Clinical Oncology (ASCO) Clinical Immuno-Oncology Symposium
27 feb 2017
Depression Puts Patients With Psoriasis at Significantly Greater Risk of Psoriatic Arthritis
Patients with psoriasis who developed depression were at a 37% greater risk of subsequently developing psoriatic arthritis, compared with patients with psoriasis who did not develop depression, according to a study published in the Journal of Investigative Dermatology
27 feb 2017
Link Between Initial Autoimmune Disorder and Later Autoimmune Disorders
Patients who develop an immune-mediated inflammatory disease (IMID) have a significantly increased risk of developing a subsequent IMID
27 feb 2017
Daptomycin Effective Against Drug-Resistant Bacteria in Paediatric Skin Infections
Daptomycin, part of a new class of antibiotics currently approved only for use in adults, is effective and well-tolerated in children with Methicillin-resistant Staphylococcus aureus (MRSA), according to a study published in the March 2017 issue of the journal Pediatrics.
27 feb 2017
FDA Approves Brodalumab to Treat Psoriasis
The US Food and Drug Administration (FDA) has approved brodalumab (Siliq) to treat adults with moderate-to-severe plaque psoriasis. Brodalumab is administered as an injection.